Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
JACS Au|March 28, 2025
Synthetic Cation Transporters Eradicate Drug-Resistant <i>Staphylococcus aureus</i>, Persisters, and BiofilmsPak-Ming Fong, Victor Yat-Man Tang, Lu Xu, et al.Biomaterials|July 14, 2026
Lipo-protein deposition strategy towards smart microspheres with bacterial toxin triggered "adsorption-pore formation-immune regulation" cascade reaction for sepsis treatmentZiyue Ling, Xijing Yang, Xianda Liu, et al.ACS Sensors|July 18, 2025
High-Sensitivity Flexible Sensors Based on Island-Bridge Configuration for Real-Time Posture Monitoring SystemsNing Ding, Yan Bai, Zhen You, et al.Pharmacoepidemiology and Drug Safety|February 3, 2021
Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycleAmarilys Vega, Rongmei Zhang, Hui-Lee Wong, et al.Nature Metabolism|March 15, 2025
Human gut microbial aromatic amino acid and related metabolites prevent obesity through intestinal immune controlZengliang Jiang, Liuqing He, Diyin Li, et al.The American Journal of Psychiatry|June 15, 2022
Mortality Among Parkinson's Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare BeneficiariesAndrew D Mosholder, Yong Ma, Sandia Akhtar, et al.Pharmacotherapy|October 19, 2024
Use of proton pump inhibitors and risk of severe COVID-19: A case-control study in United States Medicare beneficiariesAndrew D Mosholder, Hector S Izurieta, Rongmei Zhang, et al.Journal of General Internal Medicine|October 2, 2021
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for HypertensionDavid J Graham, Hector S Izurieta, Stella G Muthuri, et al.JAMA Pediatrics|May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.Vaccine|October 4, 2022
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 yearsPatricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.Pageof 4